Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).

Michael J WagnerMegan OthusSandip P PatelChris RyanAshish SangalBenjamin PowersG Thomas BuddAdrienne I VictorChung-Tsen HsuehRashmi ChughSuresh NairKirsten M LeuMark AgulnikElad SharonEdward MayersonMelissa PletsCharles BlankeHoward StreicherYoung Kwang ChaeRazelle Kurzrock

Published in: Journal for immunotherapy of cancer (2022)

NCT02834013.

Keyphrases

squamous cell carcinoma
small cell lung cancer
locally advanced
liver metastases
open label
cross sectional
double blind
placebo controlled
randomized controlled trial
radiation therapy